Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
4/5/2025
CASI Pharma Evaluates CEO's $40M Proposal for China Operations
4/5/2025
Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
4/5/2025
China and WHO Collaborate on Quality Management Training to Boost Vacc...
4/5/2025
Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy
4/5/2025
Sanofi and Cathay Capital Launch CNY 2B Healthcare Innovation Fund in ...
4/5/2025
Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
4/5/2025
BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...
4/1/2025
Biotheus Initiates Phase 3 Trial for BNT327/PM8002 in China
4/1/2025
Vivace Thera Raises $35M in Series D Financing
4/1/2025
Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
4/1/2025
China Accelerates Brain Chip Trials After Initial Success
3/31/2025
Merck KGaA Acquires Commercialization Rights to Abbisko's Pimicotinib
3/31/2025
Bio-Thera and Dr. Reddy's Execute Commercialization Deal for BAT2206 a...
3/31/2025
Roche's Ocrevus Receives Chinese Approval for MS
3/31/2025
Hengrui Medicine Expands Phase 3 Trials for Oral GLP-1R Agonist HRS-75...
3/31/2025
BMS's Opdivo and Yervoy Combio Approved in China
3/31/2025
Vcare PharmaTech Secures Series C+ Financing and Advances Clinical Pip...
3/31/2025
CDE Solicits Comments on the Draft Technical Specification of ICH M11:...
3/28/2025
Recent Executive Moves
3/28/2025
TaiMed Announces Results from Phase 2a Data on Long-Acting HIV Mainten...
3/28/2025
NiKang Thera Completes Dosing of the First Cohort in a Phase 1 Study ...
3/28/2025
AstraZeneca Advances AZD0120 CAR-T Trial for Lupus
3/28/2025
Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Pa...
3/28/2025
GenFleet Thera Reports Promising Phase II Results for Fulzerasib and C...
3/28/2025
Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...
3/28/2025
DualityBio Advances Toward Hong Kong Stock Exchange Listing
3/28/2025
Eisai to Divest China Rights for Pariet® to Peak Pharma
3/27/2025
NMPA Approves Suraxavir Marboxil for Influenza Treatment
3/27/2025
China Faces Ongoing TB Prevention Challenges Despite Declining Inciden...
3/27/2025
China Poised to Surpass Europe in Pharma Innovation, Says AZ CEO
Page:
3
/
47
Total number of articles:
1391
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit